Antibody response and safety through 12 months after booster vaccination with an investigational Lyme disease vaccine in adults: a plain language summary

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • Pfizer
  • Valneva Austria GmbH